{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:12:46Z","timestamp":1792426366408,"version":"4.5.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"\n Importance<\/jats:title>\n Obesity is associated with a higher risk of recurrence, mortality, comorbidities, treatment-related adverse effects, and poor quality of life in patients with breast cancer. Scalable interventions are needed to promote weight loss in this population.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the impact of a remotely delivered weight loss intervention (WLI) on weight change at 1 year in patients with breast cancer and obesity and to explore factors associated with weight change.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n \n The Breast Cancer Weight Loss trial is a phase 3, randomized clinical trial evaluating the impact of a telephone-based WLI on invasive disease\u2013free survival and other outcomes in women with obesity and early breast cancer at 637 sites across the US and Canada. Participants were enrolled to the study between August 2016 and February 2021. Participants included women with stage II to III,\n ERBB2<\/jats:italic>\n -negative breast cancer and a body mass index (BMI) of 27 or higher.\n <\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Participants were randomized to a 2-year, telephone-based WLI plus health education or health education alone control group.<\/jats:p>\n <\/jats:sec>\n \n Main Outcome and Measures<\/jats:title>\n The primary end point for this prespecified secondary analysis was weight change at 1 year. Weight was measured at baseline and 1 year, and changes in weight were compared between groups. Weight change was evaluated with a linear mixed-effects model including treatment group, weight over time, a time-by-group interaction, menopausal status, race and ethnicity, and hormone receptor status.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 3180 women with breast cancer and BMI of 27 and higher were included in the study; 1591 were randomized to the WLI and 1589 to the control group. At baseline, the mean (SD) age of participants was 53.4 (10.6), and the mean (SD) BMI was 34.4 (5.6). The racial and ethnic breakdown included 406 (12.8%) Black, 231 (7.3%) Hispanic or Latino, 2906 (91.4%) non-Hispanic, and 2555 (80.3%) White participants. WLI participants lost a mean of 4.3 kg (95% CI 3.9-4.6 kg), or 4.7% (95% CI, 4.3%-5.0%) of baseline body weight at 1 year vs control participants, who gained 0.9 kg (95% CI, 0.5-1.3 kg), or 1.0% (95% CI 0.1%-1.4%) of baseline body weight (\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Participants randomized to WLI experienced significant weight loss (vs control group participants) across demographic and tumor factors. WLI effect differed significantly by menopausal status, with postmenopausal participants having greater weight loss than premenopausal participants, and by race and ethnicity, with Black and Hispanic participants having less weight loss compared to other races and ethnicities.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this secondary analysis of a randomized clinical trial, a telephone-based WLI induced significant weight loss in patients with breast cancer with overweight and obesity across demographic and treatment factors. Further follow-up of the Breast Cancer Weight Loss trial will evaluate whether the WLI improves disease outcomes.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT02750826<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaoncol.2025.2738","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T15:00:26Z","timestamp":1755788426000},"page":"1194","source":"Crossref","is-referenced-by-count":15,"title":["Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II\/III Breast Cancer"],"prefix":"10.1001","volume":"11","author":[{"given":"Jennifer A.","family":"Ligibel","sequence":"first","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla V.","family":"Ballman","sequence":"additional","affiliation":[{"name":"Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"McCall","sequence":"additional","affiliation":[{"name":"Alliance Statistics and Data Management Center, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Goodwin","sequence":"additional","affiliation":[{"name":"University of Toronto\/Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Alfano","sequence":"additional","affiliation":[{"name":"Northwell Health Cancer Institute, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Bernstein","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, Victoria, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy E.","family":"Crane","sequence":"additional","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Delahanty","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Frank","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olwen","family":"Hahn","sequence":"additional","affiliation":[{"name":"Alliance Protocol Operations Office, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn L.","family":"Hershman","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith O.","family":"Hopkins","sequence":"additional","affiliation":[{"name":"Novant Health Cancer Institute, Winston-Salem, North Carolina"},{"name":"Southeast Clinical Oncology Research Consortium National Cancer Institute Community Oncology Research Program, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Irwin","sequence":"additional","affiliation":[{"name":"Yale Cancer Center, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.","family":"Mayer","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Minasian","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Nebeling","sequence":"additional","affiliation":[{"name":"Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian L.","family":"Neuhouser","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electra D.","family":"Paskett","sequence":"additional","affiliation":[{"name":"James Cancer Hospital, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Spears","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vered","family":"Stearns","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Thomson","sequence":"additional","affiliation":[{"name":"Mel & Enid Zuckerman College of Public Health, University of Arizona, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Weiss","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"White","sequence":"additional","affiliation":[{"name":"Kansas University Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Wadden","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P.","family":"Winer","sequence":"additional","affiliation":[{"name":"Yale Cancer Center, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Hudis","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical Center, New York, New York"},{"name":"American Society of Clinical Oncology, Alexandria, Virginia"},{"name":"Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann H.","family":"Partridge","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Carey","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"coi250046r1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ijc.34322","article-title":"Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta-analysis.","volume":"152","author":"Chan","year":"2023","journal-title":"Int J Cancer"},{"issue":"10","key":"coi250046r2","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","article-title":"Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies.","volume":"25","author":"Chan","year":"2014","journal-title":"Ann Oncol"},{"issue":"11","key":"coi250046r3","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/jnci\/djab023","article-title":"Association of obesity with breast cancer outcome in relation to cancer subtypes: a meta-analysis.","volume":"113","author":"Lohmann","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"coi250046r4","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1200\/JCO.2009.27.2021","article-title":"Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial.","volume":"28","author":"Sestak","year":"2010","journal-title":"J Clin Oncol"},{"issue":"19","key":"coi250046r5","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1200\/JCO.2010.33.2585","article-title":"Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.","volume":"29","author":"Pfeiler","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9","key":"coi250046r6","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv179","article-title":"Body mass index, PAM50 subtype, and outcomes in node-positive breast cancer: CALGB 9741 (Alliance).","volume":"107","author":"Ligibel","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"coi250046r7","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1002\/cncr.27527","article-title":"Obesity at diagnosis is associated with inferior outcomes in hormone receptor\u2013positive operable breast cancer.","volume":"118","author":"Sparano","year":"2012","journal-title":"Cancer"},{"issue":"5","key":"coi250046r8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/jnci\/djr543","article-title":"Race and hormone receptor\u2013positive breast cancer outcomes in a randomized chemotherapy trial.","volume":"104","author":"Sparano","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"coi250046r9","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00520-011-1089-9","article-title":"Body mass index and breast cancer treatment-related lymphedema.","volume":"19","author":"Ridner","year":"2011","journal-title":"Support Care Cancer"},{"issue":"12","key":"coi250046r10","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1016\/j.bjps.2022.10.009","article-title":"Effect of obesity on outcomes after breast reconstruction surgery, an analysis of national surgical quality improvement program.","volume":"75","author":"Ogilvie","year":"2022","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"3","key":"coi250046r11","doi-asserted-by":"publisher","first-page":"481e","DOI":"10.1097\/PRS.0000000000006543","article-title":"Obesity and breast reconstruction: complications and patient-reported outcomes in a multicenter, prospective study.","volume":"145","author":"Srinivasa","year":"2020","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"coi250046r12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/00130404-200509000-00006","article-title":"Body mass index predicts the incidence of radiation pneumonitis in breast cancer patients.","volume":"11","author":"Allen","year":"2005","journal-title":"Cancer J"},{"issue":"1","key":"coi250046r13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijrobp.2011.05.074","article-title":"Feasibility and acute toxicity of hypofractionated radiation in large-breasted patients.","volume":"83","author":"Dorn","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"coi250046r14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijrobp.2010.04.067","article-title":"Impact of the radiation boost on outcomes after breast-conserving surgery and radiation.","volume":"81","author":"Murphy","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"coi250046r15","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s00520-017-3571-5","article-title":"Disease burden and pain in obese cancer patients with chemotherapy-induced peripheral neuropathy.","volume":"25","author":"Cox-Martin","year":"2017","journal-title":"Support Care Cancer"},{"issue":"1","key":"coi250046r16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11764-021-00988-x","article-title":"Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review.","volume":"17","author":"Timmins","year":"2023","journal-title":"J Cancer Surviv"},{"issue":"12","key":"coi250046r17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002989","article-title":"Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study.","volume":"16","author":"Kabor\u00e9","year":"2019","journal-title":"PLoS Med"},{"issue":"3","key":"coi250046r18","doi-asserted-by":"publisher","first-page":"E290","DOI":"10.1152\/ajpendo.00378.2023","article-title":"Metabolic underpinnings of cancer-related fatigue.","volume":"326","author":"Zhang","year":"2024","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"18","key":"coi250046r19","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/jnci\/djt223","article-title":"Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity.","volume":"105","author":"Schmitz","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"coi250046r20","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1200\/JCO.2013.53.1517","article-title":"Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial.","volume":"32","author":"Goodwin","year":"2014","journal-title":"J Clin Oncol"},{"issue":"28","key":"coi250046r21","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1200\/JCO.2015.61.1095","article-title":"Results of the exercise and nutrition to enhance recovery and good health for you (ENERGY) trial: a behavioral weight loss intervention in overweight or obese breast cancer survivors.","volume":"33","author":"Rock","year":"2015","journal-title":"J Clin Oncol"},{"issue":"10","key":"coi250046r22","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1002\/cncr.22638","article-title":"Randomized controlled trial comparing a low-fat diet with a weight-reduction diet in breast cancer-related lymphedema.","volume":"109","author":"Shaw","year":"2007","journal-title":"Cancer"},{"issue":"7","key":"coi250046r23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/oby.2002.89","article-title":"Combining weight-loss counseling with the Weight Watchers plan for obese breast cancer survivors.","volume":"10","author":"Djuric","year":"2002","journal-title":"Obes Res"},{"issue":"2","key":"coi250046r24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10549-006-9410-x","article-title":"A cognitive behavioral therapy intervention to promote weight loss improves body composition and blood lipid profiles among overweight breast cancer survivors.","volume":"104","author":"Mefferd","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"coi250046r25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12529-010-9079-8","article-title":"Effects of a weight loss intervention on body mass, fitness, and inflammatory biomarkers in overweight or obese breast cancer survivors.","volume":"18","author":"Pakiz","year":"2011","journal-title":"Int J Behav Med"},{"issue":"1","key":"coi250046r26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41523-017-0040-8","article-title":"Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design.","volume":"3","author":"Ligibel","year":"2017","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"coi250046r27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/oby.23287","article-title":"The Breast Cancer Weight Loss trial (Alliance A011401): a description and evidence for the lifestyle intervention.","volume":"30","author":"Delahanty","year":"2022","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"coi250046r29","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/oby.2004.179","article-title":"Achieving weight and activity goals among diabetes prevention program lifestyle participants.","volume":"12","author":"Wing","year":"2004","journal-title":"Obes Res"},{"issue":"10","key":"coi250046r30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062288","article-title":"Effectiveness of weight loss interventions in breast cancer survivors: a systematic review of reviews.","volume":"12","author":"Lake","year":"2022","journal-title":"BMJ Open"},{"issue":"12","key":"coi250046r31","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1210\/clinem\/dgaa673","article-title":"Weight loss and serum lipids in overweight and obese adults: a systematic review and meta-analysis.","volume":"105","author":"Hasan","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"coi250046r32","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/jch.14661","article-title":"Effect of weight loss on blood pressure changes in overweight patients: a systematic review and meta-analysis.","volume":"25","author":"Yang","year":"2023","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"coi250046r28","volume-title":"Social Foundations of Thought and Action: A Social Cognitive Theory","author":"Bandura","year":"1986"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2837869\/jamaoncology_ligibel_2025_oi_250046_1759848034.09451.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:01:16Z","timestamp":1760626876000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2837869"}},"subtitle":["Secondary Analysis of the Breast Cancer Weight Loss (BWEL) Trial"],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2025.2738","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}